Silence Therapeutics shares are trading lower after the company reported worse-than-expected Q1 sales results.

Silence Therapeutics PLC Sponsored ADR

Silence Therapeutics PLC Sponsored ADR

SLN

0.00

Silence Therapeutics shares are trading lower after the company reported worse-than-expected Q1 sales results.